|
response to fatty acid
|
GO_0070542 |
[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a fatty acid stimulus.] |
|
carbohydrate utilization
|
GO_0009758 |
[A series of processes that forms an integrated mechanism by which a cell or an organism detects the depletion of primary carbohydrate sources,usually glucose, and then activates genes to scavenge the last traces of the primary carbohydrate source and to transport and metabolize alternate carbohydrate sources. The utilization process begins when the cell or organism detects carbohydrate levels, includes the activation of genes whose products detect, transport or metabolize carbohydrates, and ends when the carbohydrate is incorporated into the cell or organism's metabolism.] |
|
indole glucosinolate biosynthetic process
|
GO_0009759 |
[The chemical reactions and pathways resulting in the formation of indole glucosinolates, sulfur-containing compounds that have a common structure linked to an R group derived from tryptophan.] |
|
indole glucosinolate metabolic process
|
GO_0042343 |
[The chemical reactions and pathways resulting in the formation of indole glucosinolates. Glucosinolates are sulfur-containing compounds that have a common structure linked to an R group derived from tryptophan; indoles are biologically active substances based on 2,3-benzopyrrole, formed during the catabolism of tryptophan.] |
|
carbohydrate mediated signaling
|
GO_0009756 |
[The series of molecular signals mediated by the detection of carbohydrate.] |
|
positive regulation of long-chain fatty acid import across plasma membrane
|
GO_0010747 |
[Any process that increases the rate, frequency or extent of plasma membrane long-chain fatty acid transport. Plasma membrane long-chain fatty acid transport is the directed movement of long-chain fatty acids across the plasma membrane. A long-chain fatty acid has an aliphatic tail containing 13 to 22 carbons.] |
|
positive regulation of long-chain fatty acid import into cell
|
GO_0140214 |
[Any process that activates or increases the frequency, rate or extent of long-chain fatty acid import into a cell.] |
|
regulation of long-chain fatty acid import across plasma membrane
|
GO_0010746 |
[Any process that modulates the rate, frequency or extent of plasma membrane long-chain fatty acid transport. Plasma membrane long-chain fatty acid transport is the directed movement of long-chain fatty acids across the plasma membrane. A long-chain fatty acid has an aliphatic tail containing 13 to 22 carbons.] |
|
type III transforming growth factor beta receptor binding
|
GO_0034714 |
[Binding to a type III transforming growth factor beta receptor.] |
|
negative regulation of long-chain fatty acid import across plasma membrane
|
GO_0010748 |
[Any process that decreases the rate, frequency or extent of plasma membrane long-chain fatty acid transport. Plasma membrane long-chain fatty acid transport is the directed movement of long-chain fatty acids across the plasma membrane.] |
|
negative regulation of long-chain fatty acid import into cell
|
GO_0140213 |
[Any process that stops, prevents or reduces the frequency, rate or extent of long-chain fatty acid import into a cell.] |
|
pICln-Sm protein complex
|
GO_0034715 |
[A protein complex that contains pICln (CLNS1A) and several Sm proteins, including SmD1, SmD2, SmE, SmF, and SmG.] |
|
Sm-like protein family complex
|
GO_0120114 |
[A protein complex containing members of the Like-Sm family of proteins, which includes both the Sm proteins and the Lsm proteins, and which generally form hexameric or heptameric ring structures which bind to RNA. While some of these ring complexes may form independently of RNA, many only form in association with their target RNA. In addition to Lsm-family proteins, many of these complexes contain additional protein members. Members of this family of complexes include the snRNPs which comprise the majority of the spliceosome. Others are involved in the 5' to 3' degradation pathways of mRNAs in the cytoplasm and of unspliced transcripts in the nucleus, as well as other diverse roles.] |
|
GO_0034712
|
GO_0034712 |
|
|
regulation of nitric oxide mediated signal transduction
|
GO_0010749 |
[Any process that modulates the rate, frequency or extent of nitric oxide mediated signal transduction. Nitric oxide mediated signal transduction is The series of molecular signals mediated by the detection of nitric oxide (NO).] |
|
type I transforming growth factor beta receptor binding
|
GO_0034713 |
[Binding to a type I transforming growth factor beta receptor.] |
|
regulation of macrophage derived foam cell differentiation
|
GO_0010743 |
[Any process that modulates the rate, frequency or extent of macrophage derived foam cell differentiation. Macrophage derived foam cell differentiation is the process in which a macrophage acquires the specialized features of a foam cell. A foam cell is a type of cell containing lipids in small vacuoles and typically seen in atherosclerotic lesions, as well as other conditions.] |
|
SMN-Gemin2 complex
|
GO_0034718 |
[A protein complex that contains the survival motor neuron (SMN) protein and Gemin2; may form the stable core of the larger SMN complex.] |
|
SMN-Sm protein complex
|
GO_0034719 |
[A protein complex formed by the association of several methylated Sm proteins with the SMN complex; the latter contains the survival motor neuron (SMN) protein and at least eight additional integral components, including the Gemin2-8 and unrip proteins; additional proteins, including galectin-1 and galectin-3, are also found in the SMN-SM complex. The SMN-Sm complex is involved in spliceosomal snRNP assembly in the cytoplasm.] |
|
positive regulation of macrophage derived foam cell differentiation
|
GO_0010744 |
[Any process that increases the rate, frequency or extent of macrophage derived foam cell differentiation. Macrophage derived foam cell differentiation is the process in which a macrophage acquires the specialized features of a foam cell. A foam cell is a type of cell containing lipids in small vacuoles and typically seen in atherosclerotic lesions, as well as other conditions.] |